Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPaypoint Regulatory News (PAY)

Share Price Information for Paypoint (PAY)

Share Price is delayed by 15 minutes
Get Live Data
582.50    9.00 (1.57%)
Bid:
584.00
Ask:
589.00
Spread: 5.00 (0.856%)
Market Cap: £349.78m
PAY Live PriceLast checked at - London Stock Exchange

Intraday Paypoint Share Chart

Share Buyback Programme

Today 07:00

RNS Number : 4820K
PayPoint PLC
01 July 2026
 

01 July 2026

PayPoint plc

Share Buyback Programme

Commencement of Third Tranche

PayPoint plc ("PayPoint" or the "Company") today announces the commencement of the third tranche of its share buyback programme (the "Buyback Programme").

In line with the Company's previously announced intention to return at least £30 million per annum to shareholders until the end of March 2028, targeting a reduction in the Company's equity base of at least 20% over the period, the Company intends to purchase ordinary shares of £0.003611 each in the capital of the Company ("Ordinary Shares") for an aggregate maximum consideration of £25 million (the "Third Tranche").

As at 30 June 2026, the Company had returned £50 million through the first and second tranches of the Buyback Programme, with 7,860,645 Ordinary Shares purchased for cancellation and, together with the Company's share consolidation, shares in issue reduced by 17.7%. Of this £50 million, £5 million was returned during FY27 and, together with the Third Tranche, is expected to bring total FY27 shareholder returns through share buybacks to £30 million.

The Third Tranche will commence on 1 July 2026 and will end no later than 31 March 2027. The sole purpose of the Buyback Programme is to reduce the share capital of the Company and, accordingly, any Ordinary Shares purchased under the Third Tranche will be cancelled.

The Company has entered into renewed irrevocable, non-discretionary instructions with Investec Bank plc ("Investec") to conduct the Third Tranche on its behalf and to make trading decisions under the Buyback Programme independently of PayPoint. Any purchase of Shares under the Third Tranche will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes.

The Third Tranche of the Buyback Programme will be effected under the general authority to repurchase Ordinary Shares granted by the Company's Shareholders at the Company's 2025 annual general meeting (and subject to renewed authority at the Company's 2026 annual general meeting) and in accordance with Chapter 9 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse Regulation.

Any purchase of Shares pursuant to the Buyback Programme will be announced by no later than the end of the 7th daily market session following the calendar day on which such transaction occurred.

The Takeover Panel has reconfirmed that, under Rule 37.1 of the Takeover Code and the notes to that Rule, Asteriscos Patrimonial SL should continue to be treated as an "innocent bystander" and will not therefore be required to make an offer under Rule 9 as a result of any increase in its holding caused by such a buyback.

As at the date of this announcement, the Company's issued share capital consists of 59,862,665 Ordinary Shares. Each Ordinary Share carries the right to one vote in relation to all circumstances at general meetings of the Company. The Company does not hold any Ordinary Shares in treasury.

 

Enquiries

PayPoint plc

Nick Wiles, Chief Executive OfficerMobile: 07442 968960Rob Harding, Chief Financial OfficerMobile: 07525 707970

FGS Global

Rollo HeadJames ThompsonTelephone: 0207 251 3801

Investec Bank plc

Carlton NelsonHenry ReastTelephone: 0207 597 5970

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVBLFXQQLEBBB
Date   Source Headline
9th Feb 202311:08 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
9th Feb 20239:56 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - PAYPOINT PLC - Ordinary Shares
9th Feb 20239:56 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
9th Feb 20238:30 amRNSForm 8 (DD) - [PayPoint PLC]
8th Feb 20233:30 pmRNSForm 8.3 - PAYP LN
8th Feb 20233:30 pmRNSForm 8.3 - APP LN
8th Feb 20232:37 pmRNSForm 8.3 - PAYPOINT PLC
8th Feb 202311:32 amRNSForm 8.3 - PAYPOINT PLC
8th Feb 20239:04 amRNSForm 8 (DD) - PayPoint PLC
8th Feb 20238:47 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
7th Feb 20233:30 pmRNSForm 8.3 - PAYP LN
7th Feb 20233:30 pmRNSForm 8.3 - APP LN
7th Feb 20232:29 pmRNSForm 8.3 - PayPoint plc
7th Feb 202310:20 amRNSForm 8 (DD) - [PayPoint PLC]
7th Feb 20239:24 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
6th Feb 20233:30 pmRNSForm 8.3 - PAYP LN
6th Feb 20233:30 pmRNSForm 8.3 - APP LN
6th Feb 20232:55 pmRNSForm 8.3 - Paypoint Plc
6th Feb 20231:06 pmRNSForm 8.3 - PAYPOINT PLC
6th Feb 20239:23 amRNSForm 8 (DD) - PayPoint PLC
6th Feb 20238:52 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
3rd Feb 20233:30 pmRNSForm 8.3 - PAY LN
3rd Feb 20233:10 pmRNSForm 8.3 - PayPoint Plc
3rd Feb 20233:07 pmRNSForm 8.3 - PAYPOINT PLC
3rd Feb 202310:07 amRNSForm 8 (DD) - [PayPoint PLC]
3rd Feb 20239:39 amRNSForm 8.5 (EPT/NON-RI) - Paypoint Plc
2nd Feb 20233:30 pmRNSForm 8.3 - PAY LN
2nd Feb 20238:43 amRNSForm 8 (DD) - PayPoint PLC
1st Feb 20233:30 pmRNSForm 8.3 - PAY LN
1st Feb 20233:00 pmRNSForm 8.3 - PayPoint plc
1st Feb 20231:14 pmRNSForm 8 (DD) - [PayPoint PLC]
1st Feb 202310:00 amGNWTotal voting rights
31st Jan 20233:30 pmRNSForm 8.3 - PAY LN
31st Jan 202312:47 pmRNSForm 8 (DD) - [PayPoint PLC]
31st Jan 20237:10 amGNWDirectorate Change
30th Jan 20233:30 pmRNSForm 8.3 - PAY LN
30th Jan 202312:17 pmRNSForm 8.3 - PayPoint plc
30th Jan 20239:22 amRNSForm 8 (DD) - [PayPoint PLC]
27th Jan 202311:22 amRNSForm 8.3 - PayPoint plc
27th Jan 20239:10 amRNSForm 8.5 (EPT/RI)
27th Jan 20239:00 amGNWDirector Declaration
27th Jan 20238:00 amGNWDirector Declaration
26th Jan 202312:48 pmRNSForm 8.3 - PayPoint plc
26th Jan 202312:24 pmRNSForm 8 (DD) - PayPoint PLC
26th Jan 20239:18 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
26th Jan 20238:56 amRNSForm 8.5 (EPT/RI)
25th Jan 20234:16 pmRNSForm 8 (DD) - PayPoint PLC
25th Jan 20232:55 pmRNSForm 8.3 - Paypoint Plc
25th Jan 20231:36 pmRNSForm 8 (DD) - PayPoint PLC
25th Jan 202311:50 amRNSNotice of Court Hearing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.